DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
20.74
-0.08 (-0.38%)
Nov 18, 2026, 2:55 PM CST
SHA:603233 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, SHA:603233 stock has a consensus rating of "Buy" and an average price target of ¥24.03. The average 1-year stock price forecast is 15.86% higher than the current stock price, while the lowest is ¥15.00 (-27.68%) and the highest is ¥26.80 (+29.22%).
Price Target: ¥24.03 (+15.86%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:603233 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 10 | 10 | 11 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
29.57B
from 27.50B
Increased by 7.51%
Revenue Next Year
32.52B
from 29.57B
Increased by 9.98%
EPS This Year
1.30
from 1.07
Increased by 21.55%
EPS Next Year
1.52
from 1.30
Increased by 17.13%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.